Novartis opens pitch for global brand launch

Be the first to comment
Excedrin: sources say the advertising brief could relate to the US pain-relief brand
Excedrin: sources say the advertising brief could relate to the US pain-relief brand

Novartis, the pharmaceutical giant, is searching for a global advertising agency to handle the international roll-out of an over-the-counter product.

An RFI has been issued to a number of agencies, including UK-based shops, from the Denmark-based intermediary Hestbaek Consult. The brief, dubbed "Project Cool", covers the provision of advertising to support the launch of a product, which is not named in the RFI, across markets in regions including Europe, the US and Asia.

Novartis, which has its headquarters in Basel, Switzerland and has a presence in more than 140 countries, will require the appointed agency to target consumers as well as healthcare professionals.

Agency sources have speculated that the brief relates to a wider roll-out of the Novartis US pain-relief brand Excedrin. They said Excedrin, which spends around $45 million on US advertising, could be set for a global launch that will require a positive brand awareness campaign following a product recall in the US this year.

Novartis works with a number of agencies including DraftFCB London, Wunderman Switzerland and Grey Group.

SUBSCRIBE TO CAMPAIGN

Only £57 for 3 months

Includes every print & iPad edition, plus full access to Campaign online and other Brand Republic sites.

SUBSCRIBE

Looking for a new job?

Get the latest creative jobs in advertising, media, marketing and digital delivered directly to your inbox each day.

Create an Alert Now

Campaign Jobs

Thousands of jobs across advertising, creative, marketing and media

The end of false recognitions
Shares0
Share

1 The end of false recognitions

You'll be seeing less work from DDB at award shows in 2016. Here's why.

Just published